ADVANCEMENTS IN TARGETED CANCER THERAPIES: FROM MONOCLONAL ANTIBODIES TO IMMUNOTHERAPY. IJFANS [Internet]. 2022 Jan. 1 [cited 2026 Sep. 22];11(12):17887-96. Available from: https://www.ijfans.org/index.php/Journal/article/view/14322